Variable | Crude HR (95% CI) | Adjusted HR a (95% CI) | ||
---|---|---|---|---|
APAC | 0.75 | (0.71, 0.79)*** | 0.78 | (0.73, 0.83)*** |
Age, years | 1.01 | (1.01, 1.01)*** | 1.01 | (1.01,1 0.02)*** |
Sex (vs. Male ) | 1.05 | (1.00, 1.11)* | 0.95 | (0.90, 1.00) |
Comorbidity (vs. no) | Â | Â | Â | Â |
  Hypertension | 1.07 | (1.01, 1.13)* | 1.17 | (1.09, 1.24)*** |
  Dyslipidemia | 0.91 | (0.86, 0.96)*** | 1.06 | (0.99, 1.13) |
  Diabetic nephropathy | 1.19 | (1.10, 1.28)*** | 1.26 | (1.17, 1.36)*** |
  Diabetic neuropathy | 1.47 | (1.27, 1.71)*** | 1.56 | (1.34, 1.81)*** |
  Heart disease | 0.81 | (0.77, 0.86)*** | 0.77 | (0.73, 0.82)*** |
  Cardiovascular disease | 0.65 | (0.60, 0.72)*** | 0.61 | (0.56, 0.67)*** |
  Peripheral arteriolar disease | 0.81 | (0.74, 0.89)*** | 0.81 | (0.74, 0.90)*** |
Medication | Â | Â | Â | Â |
  Statin | 0.75 | (0.71, 0.79)*** | 0.74 | (0.70, 0.78)*** |
  Fibrate | 0.91 | (0.86, 0.96)*** | 1.01 | (0.95, 1.07) |
  ACEI | 0.99 | (0.94, 1.04) | - | - |